Abstract: A stable unit-dose combination for the simultaneous delivery of a short-acting oral hypoglycemic biologically active agent (such as, for example, repaglinide or nateglinide), and a long-acting oral hypoglycemic biologically active agent (such as, for example, metformin). Such a composition can be used for the treatment of non-insulin dependent diabetes mellitus (NIDDM) and the improvement of glycemic control.
| # | Name | Date |
|---|---|---|
| 1 | 1171-MUM-2002_EXAMREPORT.pdf | 2018-08-08 |
| 2 | 1171-MUM-2002-CORRESPONDENCE(IPO)-(14-3-2012).pdf | 2018-08-08 |